IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2581 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2097    
    Printed85    
    Emailed0    
    PDF Downloaded96    
    Comments [Add]    

Recommend this journal

 

 DRUG WATCH
Year : 2012  |  Volume : 44  |  Issue : 1  |  Page : 136-137

Hepatitis B viral breakthrough associated with inappropriate preservation of entecavir


Department of Infectious Diseases and Clinical Microbiology, Sakarya University, 54000, Sakarya, Turkey

Correspondence Address:
Oguz Karabay
Department of Infectious Diseases and Clinical Microbiology, Sakarya University, 54000, Sakarya
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.91889

Rights and Permissions

If virologic breakthrough is observed during chronic hepatitis B treatment, drug resistance or compliance problem should be considered. But in some cases, breakthrough depends on drug preservation conditions. We report the case of a 30-years-old man, who experienced viral breakthrough due to wrong preservation conditions of the drug.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow